Cytochrome P450 ω-Hydroxylases in Inflammation and Cancer

Amanda L Johnson1, Katheryne Z Edson2, Rheem A Totah1

  • 1Department of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle, Washington, USA.

Insights

Human CYP4 enzymes metabolize fatty acids like arachidonic acid, producing compounds such as 20-HETE. This review covers CYP4 ω-hydroxylases

Area of Science:

  • Biochemistry and Molecular Biology
  • Pharmacology and Drug Metabolism
  • Cellular and Molecular Physiology

Background:

  • Cytochrome P450 (CYP)-dependent ω-hydroxylation is a key metabolic pathway.
  • This reaction is crucial for processing endogenous compounds, particularly fatty acids like arachidonic acid.
  • Eicosanoids, derived from arachidonic acid, are significant substrates involved in various physiological processes.

Purpose of the Study:

  • To review the enzymology, tissue distribution, and substrate selectivity of human CYP4 ω-hydroxylases.
  • To elucidate the roles of these enzymes in the formation and biological effects of eicosanoid metabolites.
  • To highlight the involvement of CYP4 enzymes in inflammation and cancer progression.

Main Methods:

  • Literature review of existing research on human CYP4 ω-hydroxylases.
  • Analysis of enzymology, tissue distribution, and substrate specificity data.
  • Synthesis of information regarding the physiological roles of CYP4-derived metabolites.

Main Results:

  • Human CYP4 enzymes, including CYP4A11, CYP4F2, and CYP4F3B, hydroxylate arachidonic acid to 20-HETE.
  • 20-HETE plays a significant role in tumor progression, angiogenesis, and blood pressure regulation.
  • CYP4F3A metabolizes leukotriene B4 to 20-hydroxy leukotriene B4, regulating inflammatory responses.

Conclusions:

  • Human CYP4 ω-hydroxylases are critical catalysts in the metabolism of key eicosanoids.
  • These enzymes significantly influence biological processes, including inflammation and cancer.
  • Understanding CYP4 ω-hydroxylases offers insights into therapeutic strategies for related diseases.

Related Concept Videos

Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
22.2K
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
199
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
114
Drug Metabolism: Phase I Reactions01:17

Drug Metabolism: Phase I Reactions

A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
5.7K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.6K
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
19.2K